Sveriges mest populära poddar
Talking Points
Vetenskap

The BETAMI-DANBLOCK Trial

9 min•22 juli 2026
How does discontinuing beta-blockers after MI affect outcomes in patients without HF? Dan Atar and C. Michael Gibson break it down.

Fler avsnitt av Talking Points

Visa alla avsnitt av Talking Points
New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI
•1 tim 33 min
The PROCTOR Trial
•9 min
The SELUTION DeNovo Trial
•5 min
The VESALIUS-CV Trial
•7 min
The META-AF Trial
•5 min
Evolution of Pharmacotherapy in STEMI
•8 min
The CorCMR Trial
•6 min
The TUXEDO-2 Trial
•4 min
The FLOW Trial
•6 min
The 2024 ESC CCS Guidelines
•16 min

Talking Points med TCTMD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.